1. Diane S. Aschenbrenner is a former member of the faculty at Notre Dame of Maryland University and
折叠
Abstract
The Food and Drug Administration has approved alpelisib (Vijoice) to treat a rare noninherited genetic disorder called PIK3CA-related overgrowth spectrum.